Annual Operating Expenses
$42.75 M
+$5.84 M+15.84%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual total operating expenses is $42.75 million, with the most recent change of +$5.84 million (+15.84%) on December 31, 2023.
- During the last 3 years, IMNM annual operating expenses has risen by +$30.48 million (+248.63%).
- IMNM annual operating expenses is now at all-time high.
Performance
IMNM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$46.73 M
+$10.66 M+29.57%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly total operating expenses is $46.73 million, with the most recent change of +$10.66 million (+29.57%) on September 30, 2024.
- Over the past year, IMNM quarterly operating expenses has increased by +$29.05 million (+164.33%).
- IMNM quarterly operating expenses is now at all-time high.
Performance
IMNM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IMNM Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.8% | +164.3% |
| 3 y3 years | +248.6% | +500.1% |
| 5 y5 years | +452.1% | +500.1% |
IMNM Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.6% | at high | +583.6% |
| 5 y | 5-year | at high | +313.1% | at high | +1659.9% |
| alltime | all time | at high | +452.1% | at high | +1659.9% |
Immunome Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $46.73 M(+29.6%) |
| Jun 2024 | - | $36.06 M(+68.7%) |
| Mar 2024 | - | $21.37 M(+20.9%) |
| Dec 2023 | $42.75 M(+15.8%) | $17.68 M(+115.6%) |
| Sep 2023 | - | $8.20 M(-18.3%) |
| Jun 2023 | - | $10.04 M(+46.8%) |
| Mar 2023 | - | $6.83 M(-12.2%) |
| Dec 2022 | $36.90 M(+46.4%) | $7.79 M(-8.8%) |
| Sep 2022 | - | $8.53 M(-4.4%) |
| Jun 2022 | - | $8.93 M(-23.4%) |
| Mar 2022 | - | $11.65 M(+48.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $25.20 M(+105.6%) | $7.84 M(+1.6%) |
| Sep 2021 | - | $7.72 M(+34.5%) |
| Jun 2021 | - | $5.74 M(+47.3%) |
| Mar 2021 | - | $3.90 M(-4.3%) |
| Dec 2020 | $12.26 M(+18.5%) | $4.07 M(+44.5%) |
| Sep 2020 | - | $2.82 M(+3.8%) |
| Jun 2020 | - | $2.71 M(+2.3%) |
| Mar 2020 | - | $2.65 M(-8.1%) |
| Dec 2019 | $10.35 M(+33.6%) | $2.89 M(+6.2%) |
| Sep 2019 | - | $2.72 M |
| Dec 2018 | $7.74 M | - |
FAQ
- What is Immunome annual total operating expenses?
- What is the all time high annual operating expenses for Immunome?
- What is Immunome annual operating expenses year-on-year change?
- What is Immunome quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Immunome?
- What is Immunome quarterly operating expenses year-on-year change?
What is Immunome annual total operating expenses?
The current annual operating expenses of IMNM is $42.75 M
What is the all time high annual operating expenses for Immunome?
Immunome all-time high annual total operating expenses is $42.75 M
What is Immunome annual operating expenses year-on-year change?
Over the past year, IMNM annual total operating expenses has changed by +$5.84 M (+15.84%)
What is Immunome quarterly total operating expenses?
The current quarterly operating expenses of IMNM is $46.73 M
What is the all time high quarterly operating expenses for Immunome?
Immunome all-time high quarterly total operating expenses is $46.73 M
What is Immunome quarterly operating expenses year-on-year change?
Over the past year, IMNM quarterly total operating expenses has changed by +$29.05 M (+164.33%)